The ISAM Congress is a prestigious event that brings together experts from various fields to discuss advancements in aerosols in medicine. This year’s congress aims to foster scientific discussions around the current state-of-the-art for aerosols in medicine, providing a platform for professionals to exchange knowledge and insights.
Howard Burnett, Head of Pulmonary Category team at Aptar Pharma, stated, “We are thrilled to be a part of the ISAM Congress and support this important event. As a global leader in respiratory drug delivery systems, we recognize the significance of scientific collaboration and innovation in advancing respiratory health. The objective of all aspects of the Congress aligns perfectly with our mission to improve the outcome of patients by delivering medicines to the respiratory tract through cutting-edge aerosol technologies.”
The scientific agenda of the ISAM Congress covers a wide range of topics, including Medical Aerosols in pandemics, acute and critical care, pulmonary disease, emerging aerosol technologies, and more. In addition, the congress will host postgraduate symposia preceding the conference, featuring sessions on aerosol basics, product development, inhalation toxicology, regulatory planning, aerosol modeling and imaging, and aerosols in the acute and critical care setting. With an expected gathering of over 250 attendees, the ISAM Congress is one of the world’s largest pulmonary drug delivery and respiratory health conferences. The event attracts a diverse audience, including clinicians, respiratory health care professionals, critical care professionals, aerosol scientists, inhalation toxicologists and engineers, pharmaceutical scientists, and product development and regulatory experts. This diverse mix of attendees ensures comprehensive discussions and exchange of ideas from multiple perspectives.
Aptar Pharma’s participation at the ISAM Congress underscores the company’s commitment to advancing respiratory health through innovative drug delivery solutions. As a leading provider of OINDP drug delivery systems, Aptar Pharma’s expertise and innovative technologies play a vital role in improving patient care and treatment outcomes.
About Aptar Pharma:
Aptar Pharma is the go-to drug delivery expert, transforming ideas into market opportunities. A recognised leader in the design, development and manufacture of innovative respiratory drug delivery devices, we have a wide portfolio of MDIs, DPIs and BAIs, and a growing range of connected devices. Aptar Pharma Services provide early stage to commercialization support to accelerate and derisk the product development process. With a global manufacturing footprint of 14 GMP sites, we provide security-of-supply and local support to customers.